Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 1,075	$ 2,873
Trading debt securities	981	0
Accounts receivable, net	123	70
Inventories	34	33
Prepaid expenses and other current assets	254	316
Total current assets	2,467	3,292
Property and equipment, net	72	91
Operating lease right-of-use assets, net	184	105
Intangible assets, net	22,742	24,274
Other non-current assets	8	8
TOTAL ASSETS	25,473	27,770
Current Liabilities
Accounts payable	1,079	230
Accrued expenses	1,563	1,548
Current portion of operating lease liabilities	71	98
Total current liabilities	5,325	2,230
Royalties payable due to related parties	10,743	9,068
Operating lease liabilities	114	13
Deferred tax liability	1,545	3,141
Total liabilities	19,024	16,013
Commitments and Contingencies (see Note 16)
Stockholders' Equity
Common stock, $0.0001 par value, 60,000,000 shares authorized; 1,647,105 and 421,296 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	0	0
Additional paid-in capital	310,539	304,109
Accumulated deficit	(303,757)	(292,352)
Total stockholders' equity attributable to Catheter Precision, Inc.	6,782	11,757
Non-controlling interest	(333)	0
Total stockholders' equity	6,449	11,757
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	25,473	27,770
Series A Preferred Stock [Member]
Stockholders' Equity
Preferred Stock	0	0
Series B Preferred Stock [Member]
Stockholders' Equity
Preferred Stock	0	0
Series X Preferred Stock [Member]
Stockholders' Equity
Preferred Stock	0	0
Nonrelated Party [Member]
Current Liabilities
Short-term notes payable	0	177
Notes payable of variable interest entities, net of discount	1,297	0
Related Party [Member]
Current Liabilities
Short-term notes payable	1,696	0
Short-term notes payable of variable interest entities due to related parties	303	0
Current portion of royalties payable due to related parties	613	177
Notes payable of variable interest entities, net of discount	$ 0	$ 1,561